| 2026-08-14 | Press release | BeyondSpring Reports Second-Quarter 2026 Financial Results and Provides Corporate Update |
| 2026-07-09 | Presentation | Download Presentation Download Presentation |
| 2026-06-04 | Press release | BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long- |
| 2026-06-02 | Press release | BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus |
| 2026-05-18 | Press release | BeyondSpring Announces Poster Presentation at 2026 ASCO Annual Meeting |
| 2026-05-13 | Press release | BeyondSpring Reports First-Quarter 2026 Financial Results and Provides Corporate Update |
| 2026-04-22 | Presentation | Download Presentation
Download Presentation |
| 2026-04-22 | Press release | BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs |
| 2026-03-30 | Press release | BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026 |
| 2026-03-25 | Press release | BeyondSpring Reports 2025 Year-End Financial Results |
| 2026-01-09 | Presentation | Corporate Presentation |
| 2025-12-12 | Press release | BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving Survival in Large Phase 3 DUBLIN-3 Asi |
| 2025-12-11 | Press release | BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post |
| 2025-12-06 | Presentation | 2025 ESMO Asia Oral Presentation |
| 2025-11-12 | Press release | BeyondSpring Reports Third‑Quarter 2025 Financial Results and Provides Corporate Update |
| 2025-08-13 | Press release | BeyondSpring Reports Second‑Quarter 2025 Financial Results and Provides Corporate Update: Accelerates Momentum with Prom |
| 2025-07-07 | Press release | BeyondSpring Publishes Human Clinical Study in Med (Cell Press) Showing Plinabulin-Driven Dendritic Cell Maturation and |
| 2025-06-03 | Press release | BeyondSpring Presents Efficacy/Safety Data from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metastatic |
| 2025-05-28 | Press release | BeyondSpring Announces Poster Presentation at 2025 ASCO Annual Meeting |
| 2025-05-12 | Press release | BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update |
| 2025-02-09 | Press release | BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360◦ Conference |
| 2025-01-28 | Press release | BeyondSpring Announces $35.4 Million Sale of a Portion of Equity Interest in SEED Therapeutics to Advance Lead Asset Pli |
| 2025-01-24 | ESG report | Download |
| 2025-01-24 | ESG report | Download |
| 2025-01-23 | ESG report | Download |
| 2024-11-11 | Press release | BeyondSpring Presents Updated Efficacy Results from a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab plus Plinabu |
| 2024-09-16 | Press release | BeyondSpring Presents Efficacy/Safety Results from a Phase 2 Study of Pembrolizumab plus Plinabulin/Docetaxel in Metasta |
| 2024-09-16 | Press release | BeyondSpring Presents Final Data Analysis of DUBLIN-3 Phase 3 Study in 2L/3L EGFR Wild-type NSCLC at ESMO Congress 2024 |
| 2024-09-10 | Press release | BeyondSpring Delivers Oral Presentation at ISLAC 2024 World Conference on Lung Cancer of its Lead Anti-Cancer Asset Plin |
| 2024-06-30 | Press release | BeyondSpring Reports 2024 Year-End Financial Results and Highlights Key Clinical & Strategic Milestones |
| 2023-09-11 | ESG report | Download |
| 2021-01-14 | Presentation | BeyondSpring at 39th Annual J.P. Morgan Healthcare Conference |
| 2020-11-17 | Presentation | BeyondSpring PROTECTIVE-2 Phase 3 Trial Topline Results Update |
| 2020-09-03 | Earnings deck | BeyondSpring Second-Quarter 2020 Financial Results and Business Updates |
| 2020-08-27 | Presentation | BeyondSpring PROTECTIVE-2 Phase 3 Trial Interim Results Update |
| 2020-08-26 | Earnings deck | BeyondSpring Fourth-Quarter and Full-Year 2019 Financial Results and Operational Update |
| 2020-08-25 | Earnings deck | BeyondSpring Third-Quarter 2019 Financial Results and Operational Update |
| 2020-08-24 | Earnings deck | BeyondSpring Second-Quarter 2019 Financial Results and Operational Update |
| 2020-08-23 | Presentation | BeyondSpring at H.C. Wainwright 21st Annual Global Investment Conference |
| 2020-08-17 | Presentation | BeyondSpring at Jefferies 2019 Healthcare Conference |